0001209191-15-083871.txt : 20151208
0001209191-15-083871.hdr.sgml : 20151208
20151208094123
ACCESSION NUMBER: 0001209191-15-083871
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151204
FILED AS OF DATE: 20151208
DATE AS OF CHANGE: 20151208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JUNIPER PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000821995
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 592758596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 LIBERTY SQUARE
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 617-639-1500
MAIL ADDRESS:
STREET 1: 4 LIBERTY SQUARE
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: COLUMBIA LABORATORIES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MERRIFIELD C ANN
CENTRAL INDEX KEY: 0001247224
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10352
FILM NUMBER: 151274184
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-12-04
0
0000821995
JUNIPER PHARMACEUTICALS INC
JNP
0001247224
MERRIFIELD C ANN
C/O JUNIPER PHARMACEUTICALS, INC.
FOUR LIBERTY SQUARE 4TH FLOOR
BOSTON
MA
02109
1
0
0
0
common stock, par value $0.01
2015-12-04
4
P
0
1600
12.138
A
7129
D
This transaction was executed in a single trade at a price of $12.138. The price reported reflects the weighted-average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range described above.
/s/George O. Elston,
Attorney-in-Fact
2015-12-08